Related Experiment Videos
Vascular Ehlers-Danlos syndrome
Dominique P Germain1, Yessica Herrera-Guzman
1Clinical Genetics Unit, Hôpital Européen Georges-Pompidou, 20, rue Leblanc, 75015, Paris, France. dominique.germain@hop.egp.ap-hop-paris.fr
Annales De Genetique
|May 7, 2004
Summary
Vascular Ehlers-Danlos syndrome (EDS) is a severe inherited connective tissue disorder caused by COL3A1 gene mutations. Early diagnosis is crucial for managing complications and genetic counseling, despite no specific treatment.
Area of Science:
- Genetics
- Molecular Biology
- Rare Diseases
Background:
- Vascular Ehlers-Danlos syndrome (EDS), or EDS type IV, is a life-threatening inherited connective tissue disorder.
- It stems from mutations in the COL3A1 gene, impacting type III procollagen synthesis.
- This condition leads to severe connective tissue fragility, risking arterial, gastrointestinal, and uterine rupture.
Purpose of the Study:
- To highlight the diagnostic challenges and clinical features of Vascular EDS.
- To emphasize the importance of timely diagnosis for patient management and genetic counseling.
- To discuss the genetic basis and inheritance patterns of Vascular EDS.
Main Methods:
- Clinical feature analysis in childhood and adulthood.
- Diagnostic confirmation via SDS-PAGE of type III procollagen synthesis.
- Genetic testing for COL3A1 gene mutations.
Main Results:
- Delayed diagnosis is common, often misdiagnosed as coagulation disorders in children.
- Key adult diagnostic indicators include facial appearance, bruising, skin translucency, and organ rupture.
- Most COL3A1 mutations are private, with no clear genotype-phenotype correlation.
Conclusions:
- Vascular EDS requires multidisciplinary awareness among surgeons, radiologists, obstetricians, and geneticists.
- While no cure exists, accurate diagnosis aids in managing complications and providing genetic counseling.
- Understanding the autosomal dominant inheritance is vital for affected families.